"10.1371_journal.pone.0094733","plos one","2014-04-11T00:00:00Z","Francisco J Carrillo-Salinas; Carmen Navarrete; Miriam Mecha; Ana Feliú; Juan A Collado; Irene Cantarero; María L Bellido; Eduardo Muñoz; Carmen Guaza","Neuroimmunology Group, Functional and System Neurobiology Department, Instituto Cajal, Madrid, Spain; VivaCell Biotechnology España, Parque Científico Tecnológico de Córdoba, Córdoba, Spain; Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Hospital Universitario Reina Sofía, Universidad de Córdoba, Córdoba, Spain","Conceived and designed the experiments: EM CG. Performed the experiments: FJCS CN MM AF JAC IC MLB. Analyzed the data: FJCS CN. Wrote the paper: CG EM. Performed the in vivo experiments and BV2 in vitro experiments: FJCS MM AF. Performed the in vitro assays: CN JAC IC MLB. Analyzed the data from in vivo experiments and BV2 cells: FJCS. Analyzed the data from the in vitro assays: CN.","CN and MLB are employees of VivaCell Biotechnology España. MLB and EM have filed a PCT application “Cannabinoid quinone derivatives” (application number PCT-03494). This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.","2014","04","Francisco J Carrillo-Salinas","FJCS",9,TRUE,2,7,2,2,TRUE,TRUE,FALSE,0,NA,FALSE
